Oral Anticoagulant Therapy; Inr And Prothrombin Time - iLine microsystems microINR Instrucciones De Uso

Infection Risk Control on Multi-Patient Test System
• Healthcare professionals must wear gloves during the entire
process of the test.
• A separate lancet or lancing device should be used for each
individual.
• Used Chips, lancets and gloves might be source of infection.
Dispose of them in accordance with local regulations to
prevent infections.
• Also, comply with your centre's internal hygiene and safety
regulations.
There is a potential risk of infection. Healthcare
professionals using the microINR system on multiple
patients must take into account that all objects that
come into contact with human blood are a possible
source of infection. (See: Clinical and Laboratory
Standards Institute: Protection of Laboratory Workers
from Occupationally Acquired Infections; Approved
Guideline, Fourth Edition CLSI document M29-A4, 2014).
Electromagnetic Compatibility and Electrical Safety
The microINR Meter complies with electromagnetic
compatibility requirements according to IEC 61326-1 and
61326-2-6 standards.
Do not use the microINR Meter near sources of intense
electromagnetic radiation, as this could interfere with
its correct operation.
The microINR Meter complies with electrical safety
requirements according to standards IEC 61010-1 and IEC
61010-2-101.
The Meter must be disposed of as indicated in the WEEE
Directive (Waste Electrical and Electronic Equipment
2012/19/UE).

1.3 ORAL ANTICOAGULANT THERAPY

Oral anticoagulant therapy is given to patients to prevent
thromboembolic events such as venous thrombosis and
pulmonary embolism or those linked to atrial fibrillation or
artificial heart valves.
The treatment entails the need to monitor and adjust the
doses periodically for each patient based on a blood test.
Depending on the reason for oral anticoagulant therapy a
therapeutic range is defined for each patient meaning the
value of the test should lie within that range.

INR and Prothrombin Time

The activity of oral anticoagulants is monitored by measuring
the prothrombin time (PT) in seconds, which is the time it
takes for a fibrin clot to form. Thromboplastin is used as a
reagent to calculate the prothrombin time (PT). Depending on
the nature of this reagent and the equipment used variations
of the PT results are to be expected.
Therefore, the World Health Organization (WHO) recommended
a system standardisation method in 1977. Prothrombin time
values are converted into INR values, International Normalized
03